Hepatocellular Carcinoma Risk Panel with GALAD Score - Insights
In this “Hot Topic,” Joshua Bornhorst, Ph.D., assistant professor of laboratory medicine and pathology at Mayo Clinic, reviews biomarker component testing for hepatocellular carcinoma, explains the GALAD score, and explores GALAD score...
December 2022 - Renal - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Renal Pathology.
Organic acid disorders - Insights
Check out how Mayo Clinic Laboratories testing for organic acid metabolism disorders can help provide early diagnosis that enable prompt intervention.
Thrombotic Microangiopathies (TMA) [Test in Focus] - Insights
Meera Sridharan, M.D., Ph.D., explains Mayo Clinic Labs’ testing approach for atypical hemolytic uremic syndrome (aHUS). The serological complement panel examines nine analytes to gain a thorough understanding of the complement cascade to...
Patients with elevated LDL or "bad" cholesterol face even greater risk if their levels of small dense LDL cholesterol are also high. Vlad Vasile, M.D., Ph.D., and Leslie Donato, Ph.D., explain how Mayo Clinic Laboratories' sdLDL-c assay...
Testing aids nicotine-use cessation: Paul Jannetto, Ph.D. - Insights
Tobacco use is the leading cause of preventable death in the United States. In this test-specific episode of the "Answers From the Lab" podcast, Paul Jannetto, Ph.D., explains how Mayo Clinic Laboratories' nicotine testing benefits patients...
Neuro-Oncology Testing - Mayo Clinic Laboratories
At Mayo Clinic, we offer a comprehensive approach to neuro-oncology testing that focuses on the best outcomes for the patient
Mayo Clinic Laboratory and pathology research roundup: June 20 - Insights
This week's research roundup feature: Career decisions, training priorities, and perceived challenges for anesthesiology residents in the United States.
fabry_disease_newborn_screen-positive_follow-up.pdf
08/2024© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Fabry Disease: Newborn Screen-Positive Follow-up False-positive newborn screen Disease-causing variant identified Newborn screen result: Decreased...
newborn-screen-follow-up-elevated-c3-dc-isolated.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 05/2023 Newborn screen result: Isolated elevation of malonylcarnitine (C3-DC) Perform: Blood gas, glucose, electrolytes Order: ■ OAU / Organic Acids Screen,...